The potential of leaf extract of Pangium edule Reinw as HIV-1 protease inhibitor: A computational biology approach
Tumilaar Sefren Geiner, Fatimawali Fatimawali, Niode Nurdjannah Jane, Yunus Effendi, Rinaldi Idroes, Adam Ahmad Akroman, Ahmed Rakib, Emran Talha Bin, Tallei Trina Ekawati
Abstract
The leaf of Pangi (Pangium edule) is used as food in North Sulawesi.According to a study conducted in vitro, Pangi leaf extract suppressed the replication of the human immunodeficiency virus (HIV) inside CD4 + helper T cells.The current study aimed to determine the compounds extracted from Pangi leaves and investigate the potential of the targeted compounds against human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) using an in silico approach.Dry powder of the Pangi leaves was extracted using n-hexane and then analyzed with gas chromatographymass spectrometer (GC-MS) to obtain information about the compounds contained in Pangi leaves.Each compound's potential ability as HIV-1 PIs were evaluated by using AutoDock Vina and compared with nelfinavir and amprenavir, known as potent HIV PIs.Our present study revealed that at least 53 compounds were detected in the n-hexane extract of Pangi leaf using GC-MS analysis.The docking study revealed that (5.beta.)pregnane-3,20.beta.-diol,14.alpha.,18.alpha.-[4-methyl-3-oxo-(1-oxa-4-azabutane-1,4-diyl)]-diacetatehad the most binding affinity against the HIV-1 PIs.This finding provides a strong indication that this compound might have potential as an HIV-1 PIs.Our in silico study concluded that compound (5.beta.)pregnane-3,20.beta.-diol,14.alpha.,18.alpha.-[4-methyl-3-oxo-(1-oxa-4azabutane-1,4-diyl)]-diacetate in Pangi leaf has the potential to be further developed as an inhibitor of HIV-1 protease.Hence, it presumably serves as a very potent anti-HIV lead compound.